Competition, EU and regulatory
The Eversheds competition, EU and regulatory group is recognised as one of Europe’s leading competition/antitrust practices, with more than 30 lawyers located throughout Europe.
Competition and antitrust is a rapidly changing area. As well as substantial fines and damages claims, criminal offences and directors’ disqualification are now a real possibility in some jurisdictions. Our approach is to help you identify and deal with the risks across your business.
Several of our lawyers are recognised by legal directory Chambers as leaders in the field. This puts us in the top rank of competition/antitrust lawyers. A number of our lawyers have also spent time working in DG Competition and in national competition authorities, including sector regulators, giving us a real insight into procedure and practice across Europe.
We regularly handle the most complex M&A cases, as well as advising on a very wide range of leading-edge behavioural and investigatory work. Our approach is practical and commercial. We work alongside our clients day to day to ensure that their commercial strategies requirements and agreements meet competition law and we steer them through investigations when these arise.
Our practice also covers broader issues of EU law, state aid and procurement challenges, as well as contentious competition matters.
This information was sourced from the Eversheds website.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
Over the last few years, major power projects such as offshore wind and nuclear new build have increasingly been procured on a multi-contract basis. With this in mind, here are ten things that a developer should be aware of when drafting and negotiating contracts for a multi-contract project.
The Fair Deal sets out the principles that will ensure that staff compulsorily transferred out of the public sector will continue to have access to their existing public service pension schemes.
Analysis from The Lawyer
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?
The Mid Staffordshire Inquiry’s call for a duty of candour will have far-reaching effects on the NHS and clinical negligence - if it is ever implemented